Working… Menu
Trial record 7 of 19 for:    lomitapide

Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02765841
Recruitment Status : Withdrawn
First Posted : May 9, 2016
Last Update Posted : February 22, 2018
Information provided by (Responsible Party):
Aegerion Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : March 2017
Estimated Study Completion Date : December 2019